JP2016533332A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016533332A5 JP2016533332A5 JP2016516958A JP2016516958A JP2016533332A5 JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5 JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- nanoparticle
- self
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361881848P | 2013-09-24 | 2013-09-24 | |
| US61/881,848 | 2013-09-24 | ||
| PCT/US2014/057240 WO2015048149A1 (en) | 2013-09-24 | 2014-09-24 | Self-assembled nanoparticle vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016533332A JP2016533332A (ja) | 2016-10-27 |
| JP2016533332A5 true JP2016533332A5 (enExample) | 2017-11-02 |
Family
ID=51662365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016516958A Ceased JP2016533332A (ja) | 2013-09-24 | 2014-09-24 | 自己集合型ナノ粒子ワクチン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20150110825A1 (enExample) |
| EP (1) | EP3049107A1 (enExample) |
| JP (1) | JP2016533332A (enExample) |
| CA (1) | CA2925201A1 (enExample) |
| WO (1) | WO2015048149A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| WO2016122414A1 (en) * | 2015-01-29 | 2016-08-04 | Agency For Science, Technology And Research | Nanocapsules carrying chikungunya-associated peptides |
| WO2017079625A1 (en) * | 2015-11-06 | 2017-05-11 | University Of South Alabama | Novel platform dna vaccine |
| EP3474893A1 (en) | 2016-06-27 | 2019-05-01 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens |
| TWI634899B (zh) * | 2016-11-22 | 2018-09-11 | 國立臺灣大學 | 包含類ｂ肝病毒顆粒作為佐劑的疫苗組成物 |
| TWI683826B (zh) * | 2016-11-22 | 2020-02-01 | 國立臺灣大學 | 重組ｒｓｖ抗原 |
| CN115947873A (zh) * | 2017-04-04 | 2023-04-11 | 华盛顿大学 | 显示副粘病毒和/或肺炎病毒f蛋白的自组装蛋白纳米结构及其用途 |
| US12214052B2 (en) | 2017-08-04 | 2025-02-04 | The Hospital For Sick Children | Nanoparticle platform for antibody and vaccine delivery |
| JP2021509400A (ja) * | 2018-01-06 | 2021-03-25 | イマージェクス ヴァクシンズ ホールディング リミテッドＥｍｅｒｇｅｘ Ｖａｃｃｉｎｅｓ Ｈｏｌｄｉｎｇ Ｌｉｍｉｔｅｄ | 複数のフラビウイルスの予防および治療を目的としたｍｈｃクラスｉ関連ペプチド |
| EP3758747A1 (en) | 2018-02-28 | 2021-01-06 | University of Washington | Self-asssembling nanostructure vaccines |
| BR112020024992A2 (pt) * | 2018-06-08 | 2021-03-23 | Modalis Therapeutics Corporation | proteína cas9 modificada e uso da mesma |
| KR102076917B1 (ko) * | 2018-10-25 | 2020-02-13 | 연세대학교 산학협력단 | 자가조립 나노 입자를 제조하기 위한 유전자 재조합 발현 벡터 시스템 및 이를 이용하는 방법 |
| WO2021014385A1 (en) | 2019-07-24 | 2021-01-28 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
| CN112439056B (zh) * | 2019-08-28 | 2022-05-31 | 中国农业科学院生物技术研究所 | 基于自组装铁蛋白纳米抗原颗粒及由其制备的o型口蹄疫疫苗和应用 |
| EP4161570A1 (en) | 2020-06-05 | 2023-04-12 | GlaxoSmithKline Biologicals S.A. | Modified betacoronavirus spike proteins |
| WO2023144665A1 (en) | 2022-01-28 | 2023-08-03 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
| CN117567652B (zh) * | 2024-01-19 | 2024-05-14 | 北京安百胜生物科技有限公司 | 一种重组呼吸道合胞病毒颗粒抗原 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006017853A2 (en) * | 2004-08-11 | 2006-02-16 | Beth Israel Deaconess Medical Center, Inc. | Mutant interleukin-15-containing compositions and suppression of an immune response |
| WO2009033004A1 (en) * | 2007-09-07 | 2009-03-12 | Montana State University | Protein cages and their uses |
| US8563002B2 (en) * | 2007-12-24 | 2013-10-22 | Glaxosmithkline Biologicals, S.A. | Recombinant RSV antigens |
| WO2010075491A2 (en) * | 2008-12-24 | 2010-07-01 | University Of Rochester | Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins |
| PL3275892T3 (pl) * | 2011-05-13 | 2020-09-07 | Glaxosmithkline Biologicals S.A. | Przedfuzyjne antygeny RSV F |
| US20130049342A1 (en) * | 2011-08-25 | 2013-02-28 | James Michael Cottrell | Trailer chassis hold down system |
| WO2013044203A2 (en) * | 2011-09-23 | 2013-03-28 | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPTARTMENT OF HEALTH & HUMAN SERVICES | Novel influenza hemagglutinin protein-based vaccines |
| KR20140077169A (ko) * | 2011-09-30 | 2014-06-23 | 노바백스, 인코포레이티드 | 호흡기 세포 융합 바이러스에 대한 재조합 나노입자 ｒｓｖ ｆ 백신 |
| PL2970398T3 (pl) * | 2013-03-13 | 2024-09-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Białka f rsv przed fuzją i ich zastosowanie |
-
2014
- 2014-09-24 US US14/495,640 patent/US20150110825A1/en not_active Abandoned
- 2014-09-24 JP JP2016516958A patent/JP2016533332A/ja not_active Ceased
- 2014-09-24 WO PCT/US2014/057240 patent/WO2015048149A1/en not_active Ceased
- 2014-09-24 CA CA2925201A patent/CA2925201A1/en not_active Abandoned
- 2014-09-24 EP EP14781401.6A patent/EP3049107A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016533332A5 (enExample) | ||
| JP6957580B2 (ja) | 新規多価ナノ粒子に基づくワクチン | |
| Pimentel et al. | Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine | |
| JP2015509707A5 (enExample) | ||
| JP2015501840A5 (enExample) | ||
| JP2009523422A5 (enExample) | ||
| JP2015508284A5 (enExample) | ||
| CN114127101A (zh) | 用于治疗或预防呼吸道感染的亚单位疫苗 | |
| JP2014500724A5 (enExample) | ||
| JP2013517773A5 (enExample) | ||
| JP2012095652A5 (enExample) | ||
| JP2016501829A5 (enExample) | ||
| JP2014507146A5 (enExample) | ||
| JP2019506175A5 (enExample) | ||
| JP2012501959A5 (enExample) | ||
| JP2013517783A5 (enExample) | ||
| JP2014502156A5 (enExample) | ||
| Mao et al. | Surface display on lactic acid bacteria without genetic modification: strategies and applications | |
| CN117534735A (zh) | 腺病毒外壳蛋白衍生递送载体 | |
| JP2012515557A5 (enExample) | ||
| JP2010538619A5 (enExample) | ||
| JP2014519817A5 (enExample) | ||
| Lee et al. | Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery | |
| WO2022043449A1 (en) | Vaccines based on an antigen protein fused to a nanostructuring scaffold | |
| JP6964518B2 (ja) | ヤツメウナギ由来の配列への融合による組換えタンパク質の多量体化 |